New data with longer-term follow-up suggest that PSA screening probably lowers prostate cancer mortality — but experts stress ...

The family of a man who died from prostate cancer after care failings led to a nine-year delay in diagnosis have described ...

When high-profile figures publicly discuss their prostate cancer, the public health impact can be immediate. The media ...

Experts say prostate cancer remains a leading cause of cancer deaths in men. But new research at Yale shows that is likely to change. Dr. Nicholas Brutus, urology resident and lead author at ...

A new blood test may make it easier to detect the most dangerous forms of prostate cancer early. In a study from Karolinska ...

May 31 (Reuters) - Johnson & Johnson's prostate cancer drug Erleada used with hormone-blocking therapy six months before and after prostate surgery improved the chances of eliminating the ...